Phenothiazinium Dyes Are Active against Trypanosoma cruzi In Vitro

被引:11
|
作者
Portapilla, Gisele Bulhoes [1 ]
Pereira, Luiz Miguel [1 ]
Bronzon da Costa, Cassia Mariana [1 ]
Providello, Maiara Voltarelli [1 ]
Sampaio Oliveira, Pedro Alexandre [1 ]
Goulart, Amanda [1 ]
Anchieta, Naira Ferreira [1 ]
Wainwright, Mark [2 ]
Leite Braga, Gilberto Ubida [1 ]
de Albuquerque, Sergio [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ave Cafe SN-N, BR-14040903 Ribeirao Preto, RS, Brazil
[2] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England
基金
巴西圣保罗研究基金会;
关键词
METHYLENE-BLUE; OXIDATIVE STRESS; DRUG DISCOVERY; BENZNIDAZOLE; CHEMOTHERAPY; MECHANISMS; RESISTANCE; PARASITES; EFFICACY; MALARIA;
D O I
10.1155/2019/8301569
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chagas disease is a tropical illness caused by the protozoan Trypanosoma cruzi. The disease affects populations of the Americas and has been spread to other continents due to the migration process. The disease is partially controlled by two drugs, Benznidazole and Nifurtimox. These molecules are active in the acute phase of the infection but are usually ineffective during the symptomatic chronic phase. Several research groups have developed novel candidates to control Chagas disease; however, no novel commercial formulation is available. In this article, we described the anti-T. cruzi effects of phenothiazinium dyes in amastigote and trypomastigote forms of the parasite. Methylene Blue, New Methylene Blue, Toluidine Blue O, and 1,9-Dimethyl Methylene Blue inhibited the parasite proliferation at nanomolar concentrations and also demonstrated low toxicity in host cells. Moreover, combinations of phenothiazinium dyes indicated a synergic pattern against amastigotes compared to the Benznidazole counterparts. Phenothiazinium dyes levels of reactive oxygen species (ROS) and decreased the mitochondrial potential in trypomastigotes, indicating the mechanism of action of the dyes in T. cruzi. Our article offers a basis for future strategies for the control of Chagas disease using low-cost formulations, an important point for endemic underdeveloped regions.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Evaluation of antiparasitic effect of silver nanoparticles against Trypanosoma cruzi in vitro
    Jose, Pescador-Rojas
    Misael, Lucas-Gomez
    Eloy, Contreras-Ortiz
    Juan, Vazquez-Chagoyan
    Daniel, Bahena-Uribe
    Jose, Aparicio-Burgos
    ABANICO VETERINARIO, 2023, 13
  • [32] Activity of the sesquiterpene lactone goyazensolide against Trypanosoma cruzi in vitro and in vivo
    Milagre, Matheus Marques
    Branquinho, Renata Tupinamba
    Goncalves, Maira Fonseca
    de Assis, G. M. P.
    de Oliveira, Maykon Tavares
    Reis, L. E. S.
    Saude-Guimaraes, Denia Antunes
    de Lana, Marta
    PARASITOLOGY, 2020, 147 (01) : 108 - 119
  • [33] Differential in vitro activity of the DNA topoisomerase inhibitor idarubicin against Trypanosoma rangeli and Trypanosoma cruzi
    Jobe, Momodou
    Anwuzia-Iwegbu, Charles
    Banful, Ama
    Bosier, Emma
    Iqbal, Mubeen
    Jones, Kelly
    Lecutier, Suzanne J.
    Lepper, Kasimir
    Redmond, Matt
    Ross-Parker, Andrew
    Ward, Emily
    Wernham, Paul
    Whidden, Eleanor M.
    Tyler, Kevin M.
    Steverding, Dietmar
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2012, 107 (07): : 946 - 950
  • [34] In vitro activity of diospyrin and derivatives against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei brucei
    Yardley, V
    Snowdon, D
    Croft, S
    Hazra, B
    PHYTOTHERAPY RESEARCH, 1996, 10 (07) : 559 - 562
  • [35] The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
    Miguel, Danilo Ciccone
    Ferraz, Marcela Lencine
    Alves, Rosana de Oliveira
    Yokoyama-Yasunaka, Jenicer K. U.
    Torrecilhas, Ana Claudia
    Romanha, Alvaro Jose
    Uliana, Silvia R. B.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2010, 105 (07): : 945 - 948
  • [36] In vitro effects of suramin on Trypanosoma cruzi
    Bisaggio, Danielle Frias Ribeiro
    Adade, Camila Marques
    Souto-Padron, Thais
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (03) : 282 - 286
  • [37] PRODUCTION OF TRYPANOSOMA CRUZI CYSTS IN VITRO
    IRALU, V
    NATURE, 1964, 204 (495) : 486 - &
  • [38] In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi
    Herrera, Cristina
    Vallejos, Gabriel A.
    Loaiza, Randall
    Zeledon, Rodrigo
    Urbina, Andrea
    Sepulveda-Boza, Silvia
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (07): : 980 - 985
  • [39] In Vitro and In Vivo Studies of the Biological Activity of Novel Arylimidamides against Trypanosoma cruzi
    De Araujo, J. S.
    Da Silva, C. F.
    Batista, D. G. J.
    Da Silva, P. B.
    Meuser, M. B.
    Aiub, C. A. F.
    da Silva, M. F. V.
    Araujo-Lima, C. F.
    Banerjee, M.
    Farahat, A. A.
    Stephens, C. E.
    Kumar, A.
    Boykin, D. W.
    Soeiro, M. N. C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 4191 - 4195
  • [40] In Vitro and In Vivo Biological Effects of Novel Arylimidamide Derivatives against Trypanosoma cruzi
    Timm, Bruno Lisboa
    da Silva, Patricia Bernadino
    Batista, Marcos Meuser
    Guedes da Silva, Francisca Hildemagna
    da Silva, Cristiane Frana
    Tidwell, Richard R.
    Patrick, Donald A.
    Jones, Susan Kilgore
    Bakunov, Stanislav A.
    Bakunova, Svetlana M.
    Soeiro, Maria de Nazare C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (07) : 3720 - 3726